MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.160
-0.020 (-1.69%)
At close: Mar 6, 2026, 4:00 PM EST
1.170
+0.010 (0.86%)
Pre-market: Mar 9, 2026, 7:00 AM EST
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $48.58 million as of March 9, 2026. Its market cap has increased by 164.25% in one year.
Market Cap
48.58M
Enterprise Value
41.04M
1-Year Change
164.25%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $48.58M, a decrease of -52.94%. That is a compound annual growth rate of -25.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 48.58M | -23.18% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 153.81B |
| Bristol-Myers Squibb Company | 122.78B |
| GSK plc | 109.35B |
| Sanofi | 106.99B |
| Biogen | 27.13B |
| Grifols | 7.16B |
| Organon & Co. | 1.71B |
| Amarin Corporation | 292.50M |